# Plain Language Summary: Controlled Substances Administration Timeline Bill

This bill makes a technical change to how long doctors and other medical practitioners can wait before using controlled medications after a pharmacy delivers them. Right now, federal law sets a specific timeframe for when these powerful drugs must be administered to patients once they arrive at a medical facility. This bill extends that window, giving practitioners more time to use the medications after receiving them from the pharmacy.

The practical effect is that medical facilities will have greater flexibility in their scheduling and storage of controlled substances like opioids and other regulated drugs. Instead of being locked into a tight deadline, hospitals, clinics, and other healthcare providers can hold onto these medications for a longer period before they must be given to patients. This could help with operational efficiency—for example, if a medication arrives but a patient isn't quite ready for treatment, staff won't be under as much pressure to administer it immediately or face compliance issues.

The change primarily affects healthcare workers and medical administrators rather than patients directly. However, it's worth noting that this is part of the broader regulatory framework around controlled substances, which exists to prevent drug diversion and misuse. By extending the administration window, the bill assumes that the existing safeguards around tracking and storing these drugs remain strong enough to prevent problems. The bill doesn't appear to change any of those safety measures—it simply gives medical professionals more breathing room in their day-to-day operations.

A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

Shaheen, Jeanne

 <p><strong></strong>This bill increases the number of days&#8212;from 14 to 60&#8212;within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.</p>